Dual-modular-nanobody CAR-T cell technical platform against the solid tumor microenvironment
{{output}}
Background: CAR-T therapy is effective in hematologic cancers but faces challenges in solid tumors due to antigen heterogeneity and an immunosuppressive tumor microenvironment (TME). Systemic CTLA-4 blockade enhances immunity but... ...